Cargando…

Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies

OBJECTIVE: Despite long‐standing safe and effective use of immunoglobulin replacement therapy (IgRT) in primary immunodeficiency, clinical data on IgRT in patients with secondary immunodeficiency (SID) due to B‐cell lymphoproliferative diseases are limited. Here, we examine the correlation between a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Il‐Kang, Buckland, Matthew, Agostini, Carlo, Edgar, John David M., Friman, Vanda, Michallet, Mauricette, Sánchez‐Ramón, Silvia, Scheibenbogen, Carmen, Quinti, Isabella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849602/ https://www.ncbi.nlm.nih.gov/pubmed/30801785 http://dx.doi.org/10.1111/ejh.13223

Ejemplares similares

Current Approach in the Management of Secondary Immunodeficiency in Patients with Hematological Malignancies: Spanish Expert Consensus Recommendations
por: Boqué, Concepción, et al.
Publicado: (2023)

PB2699: CONSENSUS FROM AN EXPERT PANEL ON THE CURRENT MANAGEMENT OF SECONDARY IMMUNODEFICIENCY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES IN SPAIN
por: Boqué, Concepción, et al.
Publicado: (2023)

Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021)

A clinician survey for management of the secondary immunodeficiency caused by hematological malignancies in China
por: Ye, Chunmei, et al.
Publicado: (2021)

Primary Immunodeficiencies and Hematologic Malignancies: A Diagnostic Approach
por: Chandra, Sharat, et al.
Publicado: (2022)

Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases
por: Ballow, Mark, et al.
Publicado: (2022)

Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study
por: Gangneux, Jean-Pierre, et al.
Publicado: (2018)

Incidence of Hospital-Acquired Pneumonia, Bacteraemia and Urinary Tract Infections in Patients with Haematological Malignancies, 2004–2010: A Surveillance-Based Study
por: Huoi, Catherine, et al.
Publicado: (2013)

Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study
por: Michallet, Mauricette, et al.
Publicado: (2022)

Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency
por: Pulvirenti, Federica, et al.
Publicado: (2018)

Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies
por: Hammarström, Helena, et al.
Publicado: (2022)

Short- and long-term outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis
por: Faucher, Etienne, et al.
Publicado: (2016)

Disseminated histoplasmosis mimicking hematologic malignancy in a patient with human immunodeficiency virus
por: Kallen, Michael E., et al.
Publicado: (2022)

Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies
por: Pan, Hua, et al.
Publicado: (2016)

Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy
por: Lee, Jeongsoo, et al.
Publicado: (2020)

Secondary osteosarcoma arising after treatment for childhood hematologic malignancies
por: Okada, Atsushi, et al.
Publicado: (2009)

Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies
por: Andreescu, Mihaela
Publicado: (2023)

Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?
por: Mertowska, Paulina, et al.
Publicado: (2023)

Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy
por: Sánchez-Ramón, Silvia, et al.
Publicado: (2016)

Sonographic features of secondary involvement of skin and subcutaneous tissues by hematologic malignancies
por: Lyu, Heng, et al.
Publicado: (2022)

Biosimilar epoetin for the management of chemotherapy-induced anemia in elderly patients
por: Kurtz, Jean-Emmanuel, et al.
Publicado: (2016)

Health Related Quality of Life in Common Variable Immunodeficiency
por: Quinti, Isabella, et al.
Publicado: (2012)

The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data
por: Odnoletkova, Irina, et al.
Publicado: (2018)

Inonotosis in Patient with Hematologic Malignancy
por: Fernández-Cruz, Ana, et al.
Publicado: (2018)

Hepatomegaly and fever at the time of neutrophil recovery revealing L-asparaginase toxicity in the treatment of acute lymphoblastic leukemia
por: Saison, Julien, et al.
Publicado: (2014)

Role of Notch Receptors in Hematologic Malignancies
por: Gragnani, Laura, et al.
Publicado: (2020)

Anti-COVID-19 Vaccination in Patients with Autoimmune-Autoinflammatory Disorders and Primary/Secondary Immunodeficiencies: The Position of the Task Force on Behalf of the Italian Immunological Societies
por: D’Amelio, Raffaele, et al.
Publicado: (2021)

Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype
por: Scarpa, Riccardo, et al.
Publicado: (2020)

Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency
por: Fernandez Salinas, Ane, et al.
Publicado: (2022)

Retroviral rebound syndrome after treatment discontinuation in a 15 year old girl with HIV attracted through mother-to-child transmission: case report
por: Friman, Vanda, et al.
Publicado: (2007)

Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients
por: Volk, Timo, et al.
Publicado: (2021)

Editorial: Trained Immunity-Based Vaccines
por: Subiza, Jose Luis, et al.
Publicado: (2021)

Editorial: Tumour microenvironment heterogeneity in hematological malignancies
por: Deaglio, Silvia, et al.
Publicado: (2023)

Surgical Roles for Spinal Involvement of Hematological Malignancies
por: Kim, Sang-Il, et al.
Publicado: (2017)

Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management
por: Sánchez-Ramón, Silvia, et al.
Publicado: (2019)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e89btm9le5746t7ot3thg9r2sj